Raptor Pharmaceutica (RPTP)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 03-2015 | 12-2014 | 09-2014 | 06-2014 | 03-2014 | |
| Sales | 20,453 | 17,286 | 23,764 | 16,313 | 12,134 |
| Cost of Goods | 3,722 | 3,190 | 3,917 | 995 | 1,314 |
| Gross Profit | 16,731 | 14,096 | 19,847 | 15,318 | 10,820 |
| Operating Expenses | 32,113 | 30,229 | 24,995 | 25,398 | 21,925 |
| Operating Income | -14,660 | -15,943 | -4,231 | -9,085 | -10,791 |
| Interest Expense | 4,498 | 3,115 | 4,380 | 3,497 | 2,979 |
| Other Income | -504 | 184 | 2,571 | -105 | -1,115 |
| Pre-tax Income | -19,662 | -18,874 | -6,040 | -12,687 | -14,885 |
| Income Tax | 21 | 51 | -9 | 6 | 6 |
| Net Income Continuous | -19,683 | -18,925 | -6,031 | -12,693 | -14,891 |
| Net Income | $-19,683 | $-18,925 | $-6,031 | $-12,693 | $-14,891 |
| EPS Basic Total Ops | -0.28 | -0.29 | -0.10 | -0.20 | -0.24 |
| EPS Basic Continuous Ops | -0.28 | -0.29 | -0.10 | -0.20 | -0.24 |
| EPS Diluted Total Ops | -0.28 | -0.29 | -0.10 | -0.20 | -0.24 |
| EPS Diluted Continuous Ops | -0.28 | -0.29 | -0.10 | -0.20 | -0.24 |
| EPS Diluted Before Non-Recurring Items | -0.28 | -0.29 | N/A | N/A | N/A |
| EBITDA(a) | $-13,996 | $-14,836 | $-3,341 | $-8,744 | $-10,466 |